Literature DB >> 16686607

New insights into the molecular biology and targeted therapy of cutaneous T-cell lymphomas.

Claus-Detlev Klemke1, Sergij Goerdt, David Schrama, Jürgen C Becker.   

Abstract

Cutaneous T-cell lymphoma is an extra-nodal non-Hodgkin lymphoma of mature T cells. These tumor cells home to and persist in the skin,producing a broad spectrum of clinical entities. Recent results of basic research on tumor biology and tumor immunology as well as molecular genetics of cutaneous T-cell lymphoma have fostered the development of new therapeutic approaches. Several clinical trials testing these targeted therapies have shown encouraging results. This article provides an overview of recent research developments and therapeutic strategies for cutaneous T-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686607     DOI: 10.1111/j.1610-0387.2006.05982.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  8 in total

1.  Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphoma.

Authors:  Michael Forgber; Sylke Gellrich; Tumenjargal Sharav; Wolfram Sterry; Peter Walden
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

2.  [Systemic treatment of cutaneous lymphomas].

Authors:  C-D Klemke
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

3.  BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.

Authors:  S Esmailzadeh; Y Huang; M-W Su; Y Zhou; X Jiang
Journal:  Leukemia       Date:  2015-01-12       Impact factor: 11.528

Review 4.  AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders.

Authors:  Sharmin Esmailzadeh; Xiaoyan Jiang
Journal:  Oncotarget       Date:  2011-12

Review 5.  Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.

Authors:  Jochen Utikal; Dirk Schadendorf; Selma Ugurel
Journal:  Arch Dermatol Res       Date:  2007-03       Impact factor: 3.017

Review 6.  Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.

Authors:  Alexandra Ion; Iris Maria Popa; Laura Maria Lucia Papagheorghe; Cristina Lisievici; Mihai Lupu; Vlad Voiculescu; Constantin Caruntu; Daniel Boda
Journal:  Dis Markers       Date:  2016-10-16       Impact factor: 3.434

7.  Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.

Authors:  Ieva Bagdonaite; Hans H Wandall; Ivan V Litvinov; Claudia Nastasi; Jürgen C Becker; Sally Dabelsteen; Carsten Geisler; Charlotte M Bonefeld; Qian Zhang; Mariusz A Wasik; Youwen Zhou; Denis Sasseville; Niels Ødum; Anders Woetmann
Journal:  Oncotarget       Date:  2015-06-10

8.  Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.

Authors:  Jingkai Xu; He Huang; Shangshang Wang; Yanzhen Chen; Xueli Yin; Xuejun Zhang; Yaohua Zhang
Journal:  Arch Dermatol Res       Date:  2019-11-01       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.